E-LIB Suche - Ergebnisse für: Galldiks, N.

1

Compressed Sensing beschleunigte 4D-MR- Flussbildgebung des..:

Jaeger, I. E.. , 2023

Link: https://nbn-resolving.de..

2

JS09.6.A ASSESSMENT OF RESPONSE TO REGORAFENIB IN RECURRENT..:

Werner, J ; Lohmann, P ; Kabbasch, C...
Neuro-Oncology. 25 (2023) Supplement_2 - p. ii13-ii13 , 2023

Link: https://doi.org/10.1093/..

3

OS06.6.A FLAIR-SIGNAL INTENSITY CHANGE AS A PREDICTOR OF PR..:

Flies, C M ; Friedrich, M ; Lohmann, P...
Neuro-Oncology. 25 (2023) Supplement_2 - p. ii17-ii18 , 2023

Link: https://doi.org/10.1093/..

4

P11.20.B ASSOCIATION OF HAND-FOOT SKIN REACTIONS WITH SURVI..:

Werner, J ; Hau, P ; Kowalski, T...
Neuro-Oncology. 25 (2023) Supplement_2 - p. ii76-ii77 , 2023

Link: https://doi.org/10.1093/..

5

P01.02.A WHOLE-BRAIN STRUCTURAL CONNECTIVITY PREDICTS COGNI..:

Friedrich, M ; Stoffels, G ; Filss, C P...
Neuro-Oncology. 25 (2023) Supplement_2 - p. ii25-ii26 , 2023

Link: https://doi.org/10.1093/..

6

P01.01.A THE IMPACT OF BRAIN LESIONS ON HEALTH-RELATED QUAL..:

Kocher, M ; Heinzel, A ; Mottaghy, F M...
Neuro-Oncology. 25 (2023) Supplement_2 - p. ii25-ii25 , 2023

Link: https://doi.org/10.1093/..

7

Immuntherapie und zielgerichtete Therapie von Gliomen:

Werner, J.-M. ; Ceccon, G. ; Fink, G. R..
best practice onkologie. 17 (2022) 9 - p. 446-456 , 2022

Link: https://doi.org/10.1007/..

8

KS02.7.A Impact of FET PET on multidisciplinary neurooncolo..:

Ceccon, G S ; Werner, J ; Ruge, M I...
Neuro-Oncology. 24 (2022) Supplement_2 - p. ii4-ii5 , 2022

Link: https://doi.org/10.1093/..

9

P01.01.A Lesion-Function Analysis from Multimodal Imaging a..:

Kocher, M ; Jockwitz, C ; Lohmann, P...
Neuro-Oncology. 24 (2022) Supplement_2 - p. ii23-ii23 , 2022

Link: https://doi.org/10.1093/..

10

Immuntherapie und zielgerichtete Therapie von Gliomen:

Werner, J.-M. ; Ceccon, G. ; Fink, G. R..
DGNeurologie. , 2022

Link: https://doi.org/10.1007/..

11

KS05.5.A Alterations in white matter fiber density associat..:

Friedrich, M ; Farrher, E ; Caspers, S...
Neuro-Oncology. 24 (2022) Supplement_2 - p. ii5-ii6 , 2022

Link: https://doi.org/10.1093/..

12

P11.53.B Efficacy and tolerability of regorafenib in pretre..:

Werner, J ; Wolf, L ; Tscherpel, C...
Neuro-Oncology. 24 (2022) Supplement_2 - p. ii70-ii70 , 2022

Link: https://doi.org/10.1093/..

13

P15.05.A Prediction of response to lomustine-based chemothe..:

Wollring, M M ; Werner, J ; Bauer, E K...
Neuro-Oncology. 24 (2022) Supplement_2 - p. ii84-ii85 , 2022

Link: https://doi.org/10.1093/..

14

P13.03.A Radiomics for the non-invasive assessment of the P..:

Meißner, A ; Gutsche, R ; Galldiks, N...
Neuro-Oncology. 24 (2022) Supplement_2 - p. ii81-ii81 , 2022

Link: https://doi.org/10.1093/..

15

P17.19.B Incidence of treatment-associated imaging changes ..:

Flies, C M ; Friedrich, M ; Lohmann, P...
Neuro-Oncology. 24 (2022) Supplement_2 - p. ii93-ii93 , 2022

Link: https://doi.org/10.1093/..